SNShiro Niiyama

Shiro Niiyama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shiro Niiyama has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nonpigmented Adenoid Subtype of Basal Cell Carcinoma: A Case Report

    by Yasunori Ichimura, Shiro Niiyama, Akiko Hirata

    Introduction: Basal cell carcinoma (BCC) is the most common skin cancer, with a rising incidence globally. We encountered a patient with the nonpigmented adenoid subtype of BCC. The nonpigmented subtype of BCC accounts for only a small percentage of cases of BCC in the Asian population, with the adenoid subtype of BCC also being rare in all human ethnicities. Case Presentation: An 82-year-old woman presented to us with a growth in the inner canthus of the left eye, which had been slowly evolving for about 1 year. The lesion had failed to respond to a variety of topical treatments. Physical examination revealed a reddish plaque in the inner canthus of the left eye that measured 10 × 6 mm in size. Dermoscopic evaluation showed blue-gray globules and arborizing telangiectasia. Histopathological examination confirmed the diagnosis of adenoid BCC. Conclusion: We analyzed the data of patients with the adenoid subtype of BCC in the Japanese population and found the possibility that this variant of BCC was often nonpigmented. Furthermore, we collected the dermoscopic findings of patients with the adenoid subtype of BCC; however, the data revealed no other noteworthy characteristics at present. We expect that further characterization of these two variants of BCC through accumulation of data from clinical cases will contribute to facilitating early diagnosis.

  • Open Access

    Arteriovenous Fistula Pseudoaneurysm Mimicking Cutaneous a Neoplasm Arising from a Stenosed Arteriovenous Fistula

    by Hayato Hanada, Shiro Niiyama, Akiko Hirata

    A 72-year-old woman was referred for noticing a nodule on the arteriovenous fistula spontaneous obstruction. Physical examination revealed a dark reddish, non-pulsatile nodule in the right forearm that measured 21 × 13 mm, bled easily, and was partially crusted. During the course of examinations, the patient developed trauma-induced excessive bleeding from the lesion. At the initial examination, based on the clinical findings, we considered the possibility of cutaneous neoplasm. Eventually, we made the diagnosis of an organized hematoma and an arteriovenous fistula pseudoaneurysm. No previous report of an arteriovenous fistula pseudoaneurysm mimicking a neoplasm arising from a stenosed arteriovenous fistula, as in our case, has been available. An arteriovenous fistula pseudoaneurysm can arise even from a stenosed arteriovenous fistula, so that an early diagnosis can be made and impending rupture prevented.

    • 1 December 2024
      • Vol. 32  (4) , 212-213

    Vogt-Koyanagi-Harada Disease in which Poliosis and Alopecia Occurred after a Long Period of Time.

    by Shiro Niiyama, Yuki Yokouchi, Hidetsugu Fukuda

    Vogt-Koyanagi-Harada (VKH) disease is a multisystem autoimmune disorder affecting melanocyte-containing tissues such as the eyes, ears, central nervous system, and skin. A 55-year-old Japanese male presented with an 8-week history of increasing diffuse hair loss. A physical examination revealed diffuse alopecia of the scalp. He lost all body hair, including the eyebrows and eyelashes. All the remaining scalp hair was white, but no vitiligo was present. Laboratory examination found nearly normal values and the HLA profile was DR4. The patient was initially diagnosed with alopecia universalis and received 15 intradermal injections of 1 mg of triamcinolone acetonide to the same region. As a result, although no hair growth was observed, the patient's hair turned black in the area of the local injections (Figure 1, a). We therefore reviewed the patient's medical history again and found that he had developed bilateral uveitis at the age of 20 years and received high-dose intravenous corticosteroid therapy. He also consulted an ophthalmologist at the time, but there were no abnormal findings. Two biopsies were performed in both the white and black hair. Histopathologically, no melanin was detected in the white hair (Figure 1, b), whereas the black hair demonstrated melanin granules in the hair matrix (Figure 1, c). Treatment was started with oral prednisolone at a dose of 30 mg per day, with the dose gradually reduced by 5 mg every 2 weeks. When the treatment was discontinued, a considerable part of the hair had turned black (Figure 1, d). VKH disease typically has three phases. During the first phase, patients may experience headache, muscle weakness, and meningism. Recovery is usually complete, and is followed by the second phase days to weeks later, in which patients may develop uveitis, iridocyclitis, choroiditis, and dysacousia. The third phase begins weeks to months later as the uveitis improves. The third phase is the convalescent phase, and is characterized by alopecia, poliosis, and vitiligo; usually occurring in that order. These dermatologic manifestations have been reported in about 50% of patients by two months after disease onset (1). Poliosis is either patchy or diffuse and occurs in up to 90% of the patients (2). In our case, the amount of white hair began to increase 20 years after the onset of uveitis, and all the hair turned white over the course of a few years. Such a late onset of poliosis has not been reported so far, and steroid treatment resulted in repigmentation even approximately 15 years after all the hair turned white. Reversal of poliosis and vitiligo in the VKH setting has been reported in 6 of 22 (27%) patients (3). All patients with reversal of poliosis and vitiligo had no intraocular inflammation. The reversal may represent a good prognostic sign. Our patient also experienced no recurrence of ocular symptoms. Alopecia can be observed in 50%-70% of cases of VKH disease and occurs a few weeks to a few months after onset of ocular or meningeal symptoms (4). It presents as diffuse, although it may be patchy. Alopecia usually heals after a variable period of time with steroid or immunosuppressive therapy. Microscopically, alopecia in VKH disease shows a peribulbar mononuclear infiltrate with increased telogen/catagen/anagen follicles (2). So far, no reports have compared the histopathological findings of white and black hair in the same patients. No inflammatory infiltrate was present in our case. The reason for this may be the chronic phase of the disease. Our patient developed alopecia 35 years after the onset of uveitis, and such a late onset of alopecia as well as poliosis has not been reported so far. Unfortunately, we have observed no growth of scalp hair. The patient continues to attend follow-up, with special attention to the potential onset of vitiligo.

  • Efficacy of autologous dermal sheath cup cell transplantation in male and female pattern hair loss: A Single‐Arm, Multi‐Center, phase III equivalent clinical study

    by Kazutoshi Harada, Manabu Ohyama, Shiro Niiyama, Ryokichi Irisawa, Kenichiro Mae, Miho Mori, Hiroko Wakimoto, Misaki Kinoshita‐Ise, Masahiro Fukuyama, Reina Hayakawa, et al.

    A previous, proof‐of‐concept clinical study suggested that dermal sheath cup cell injections into the affected areas of male/female pattern hair loss (PHL) may have some amelioratory effects, the clinical efficacy of which needs further examination. A phase III equivalent clinical study was conducted to further probe the therapeutic potential of this novel approach and verify its safety and efficacy in improving the appearance of PHL. Thirty‐six participants with PHL were injected with dermal sheath cup cell harvested from non‐affected occipital hair follicles twice in quarterly intervals. Global photographic assessment and phototrichogram were performed in a blinded manner. Patient‐reported outcomes were assessed for 12 months. On global photographic assessment, 30% of the participants showed improvement. The analysis of phototricogram data detected the increases in the cumulative hair diameter, hair cross‐sectional area, and mean hair diameter of 107.6 ± 152.6 μm/cm2, 13069.1 ± 10960.7 μm2/cm2, and 0.9 ± 0.9 μm (ratios vs. baseline: +1.4%, +3.4%, and +2.2%), respectively. The female and high terminal hair ratio groups achieved better improvement. Of the total participants, 62.9% noted some degree of improvement. No serious adverse events were detected. This novel approach exhibited visible effects while ensuring safety and patient satisfaction. Therefore, it holds promise as a possible therapeutic option for treating PHL, especially in women.


  • Recalcitrant multiple warts in GATA2 deficiency treated with systemic etretinate

    by Shiro Niiyama, Hidetsugu Fukuda, Akiko Hirata, Sayaka Takenaka, Takeshi Isoda

  • Open Access

    Niche formed by bone morphogenetic protein antagonists gremlin 1 and gremlin 2 in human hair follicles

    by Shiro Niiyama, Yumiko Ishimatsu‐Tsuji, Jiro Kishimoto


    • 1 January 2022
      • Vol. 30  (4) , 263-264

    Mammary Paget's Disease Presenting as an Annular Plaque

    by Chinatsu Matsumoto, Shiro Niiyama, Takuya Nagata, Toshiaki Oharaseki, Hidetsugu Fukuda

    Dear Editor,Mammary Paget's disease (MPD) is an adenocarcinoma localized within the epidermis of the nipple and/or the areola of the breast, and it is as a rule associated with a carcinoma of the underlying lactiferous ducts, where it usually starts. MPD is relatively rare, observed in 0.7-4.3% of all breast cancers (1). We present a patient with MPD and atypical clinical finding as an annular plaque. A 74-year-old Japanese woman with a past medical history of hypothyroidism presented with a 6-month history of an itching plaque on the left areola. The patient had been treated with the application of topical steroids for a duration of approximately 5 months, and showed no clinical improvement. Physical examination showed a pink plaque encircling the nipple on the left areola (Figure 1, a). The right nipple and areola appeared normal (Figure 1, b). No palpable masses were detected within either breast. A 3.5 mm punch biopsy of the skin at the 6 o'clock position of the left areola was performed. Histological examination showed single and small aggregations of atypical cells with large hyperchromatic nuclei and pale-staining, ample cytoplasm throughout the epidermis. There was a lymphocytic infiltration in the dermis (Figure 1, c). Immunohistochemical studies were positive for CK7 and negative for S-100 and HMB45. With the diagnosis of MPD, the patient underwent a partial mastectomy of the left breast center area, consisting of surgical excision of the left nipple, the adjacent surrounding areolar skin, and subcutaneous tissues. Subsequently, radiation therapy for the residual breast was prepared. As has been described in detail by Kanitakis, the skin lesion develops insidiously as a scaly, fissured, or oozing erythema of the nipple and, more rarely, the areola. Advanced lesions present as a well-demarcated, round, ovoid, or polycyclic eczema-like plaque with a pink or red hue. It is occasionally slightly infiltrated and has an erosive, oozing, scaly, or crusted surface. The lesions are almost invariably unilateral, showing centrifugal spread. Retraction or ulceration of the nipple are often noted (1). The present case exhibited a very rare clinical finding of a plaque encircling the nipple, which has not been reported previously. It was initially difficult to establish the diagnosis of MPD, and biopsy was needed to obtain a definitive diagnosis. Differential diagnosis of MPD comprises eczema as atopic dermatitis or contact dermatitis, erosive adenomatosis, and malignant skin condition such as Bowen's disease, superficial basal cell carcinoma, or superficially spreading melanoma. As in the present case, individuals presenting with an annular plaque are often considered to have sebaceous hyperplasia. Sebaceous hyperplasia is a common, benign skin condition involving hypertrophy of the sebaceous glands, common in middle-aged or older adults (2). These lesions can be single or multiple and manifest as yellow, soft, small papules. These papules are occasionally seen around the nipple, forming an annular plaque. In general, sebaceous hyperplasia is described as yellow-colored papules among Caucasians. However, caution is needed, since it is characterized by skin-colored papules among some Asians.In the present case, some pigmentation (2 to 3 mm in diameter) was observed on the left nipple. Pigmented MPD have been reported, and the mechanism underlying the pigmentation is not yet fully understood, but it has been proposed that Paget cells may release melanocytic chemoattractants or basic fibroblast growth factors that stimulate the proliferation of melanocytes within the tumor nests (3). The possibility of physiological pigmentation cannot be ruled out in the present case; on the other hand, the possibility of pigmented MPD cannot be ruled out either, since no pigmentation was observed on the right nipple.

  • Open Access

    The Review of the Difference between Patients and Physicians in Terms of Severity Assessment and Therapeutic Goals in Androgenetic Alopecia in Japan

    by Yuya Harada, Shiro Niiyama, Hidetsugu Fukuda

    We often come across differences in the severity of androgenetic alopecia (AGA) as assessed subjectively by the patients themselves and objectively by the attending physicians. For the purpose of examining the differences in the assessment of AGA between patients and physicians, we presented the Norwood classification to male patients and the Shiseido classification to female patients and asked them to assess the degree of hair loss by themselves. We compared the results with the severity as assessed by 2 specified dermatologists. The results show that the assessments of the severity of AGA were consistent between the patients and physicians in 42% (15/36) of cases, the physicians reported a higher grade of severity than the patients themselves in 30% (11/36) of cases, and the patients reported a higher grade of severity than the physicians in 28% (10/36) of cases; however, the Wilcoxon signed rank statistical analysis showed no significant difference between the patients and physicians assessments. AGA should be treated in accordance with individual symptoms and wishes and not a standardized treatment protocol.

  • Open Access

    Eosinophilic Vulvar Leukoderma

    by Kaya Nakada, Shiro Niiyama, Toshiaki Oharaseki, Hidetsugu Fukuda

    We report the case of a 54-year-old woman with asthma and atopic dermatitis who presented a white spot on the genitalia. Histologic examination showed numerous eosinophils in the epithelium and the dermis. Eosinophilic esophagitis is defined as an esophageal disease characterized clinically by symptoms related to esophageal dysfunction and histologically by an eosinophil-predominant inflammation. We discuss the possible relationship between the two diseases.